Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations: a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations : a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system. / Sassene, Philip J.; Mosgaard, Mette D.; Löbmann, Korbinian; Mu, Huiling; Larsen, Flemming Hofmann; Rades, Thomas; Müllertz, Anette.

In: Molecular Pharmaceutics, Vol. 12, No. 11, 2015, p. 4067-4076.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sassene, PJ, Mosgaard, MD, Löbmann, K, Mu, H, Larsen, FH, Rades, T & Müllertz, A 2015, 'Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations: a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system', Molecular Pharmaceutics, vol. 12, no. 11, pp. 4067-4076. https://doi.org/10.1021/acs.molpharmaceut.5b00498

APA

Sassene, P. J., Mosgaard, M. D., Löbmann, K., Mu, H., Larsen, F. H., Rades, T., & Müllertz, A. (2015). Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations: a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system. Molecular Pharmaceutics, 12(11), 4067-4076. https://doi.org/10.1021/acs.molpharmaceut.5b00498

Vancouver

Sassene PJ, Mosgaard MD, Löbmann K, Mu H, Larsen FH, Rades T et al. Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations: a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system. Molecular Pharmaceutics. 2015;12(11):4067-4076. https://doi.org/10.1021/acs.molpharmaceut.5b00498

Author

Sassene, Philip J. ; Mosgaard, Mette D. ; Löbmann, Korbinian ; Mu, Huiling ; Larsen, Flemming Hofmann ; Rades, Thomas ; Müllertz, Anette. / Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations : a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system. In: Molecular Pharmaceutics. 2015 ; Vol. 12, No. 11. pp. 4067-4076.

Bibtex

@article{8b07e726c0c14332a00ff7ef5f3425f7,
title = "Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations: a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system",
keywords = "lipid-based drug delivery systems, self-nanoemuslifying drug delivery systems, nuclear magnetic resonance spectroscopy, differential scanning calorimetry, solid-state characterization, amorphous, weak bases, interactions",
author = "Sassene, {Philip J.} and Mosgaard, {Mette D.} and Korbinian L{\"o}bmann and Huiling Mu and Larsen, {Flemming Hofmann} and Thomas Rades and Anette M{\"u}llertz",
year = "2015",
doi = "10.1021/acs.molpharmaceut.5b00498",
language = "English",
volume = "12",
pages = "4067--4076",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "11",

}

RIS

TY - JOUR

T1 - Elucidating the molecular interactions occurring during drug precipitation of weak bases from lipid-based formulations

T2 - a case study with cinnarizine and a long chain self-nanoemulsifying drug delivery system

AU - Sassene, Philip J.

AU - Mosgaard, Mette D.

AU - Löbmann, Korbinian

AU - Mu, Huiling

AU - Larsen, Flemming Hofmann

AU - Rades, Thomas

AU - Müllertz, Anette

PY - 2015

Y1 - 2015

KW - lipid-based drug delivery systems

KW - self-nanoemuslifying drug delivery systems

KW - nuclear magnetic resonance spectroscopy

KW - differential scanning calorimetry

KW - solid-state characterization

KW - amorphous

KW - weak bases

KW - interactions

U2 - 10.1021/acs.molpharmaceut.5b00498

DO - 10.1021/acs.molpharmaceut.5b00498

M3 - Journal article

C2 - 26393273

VL - 12

SP - 4067

EP - 4076

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 11

ER -

ID: 152994306